Arcutis Biotherapeutics (ARQT) Stock
Arcutis Biotherapeutics (ARQT) closed at $27.33 on Nov 17, 2026; its Tenet Score is 43 of 100 against 340 Healthcare peers.
14 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $27.33
- Nov 17, 2026
- Market cap
- $3.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 124.2×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 19.30 – 34.80
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 43/100
- Weak · 340 Healthcare peers
Industry: Drugs
Arcutis Biotherapeutics Inc scores 43/100. Weak. Strongest on quality, value is the soft spot, trading at 124× earnings versus 340 Healthcare peers. Insufficient inputs: Tenet 43 is built from 3 of 4 pillars, from 90% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Relay Therapeutics IncRLAY | 43 | $3.8B |
| Organon & Co.OGN | 45 | $3.7B |
| Amylyx Pharmaceuticals IncAMLX | 56 | $3.6B |
| Enliven Therapeutics IncELVN | 60 | $3.5B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.5B |
| Viking Therapeutics IncVKTX | 36 | $3.4B |
| Supernus Inc.SUPN | 53 | $3.4B |
| Acadia Pharmaceuticals IncACAD | 65 | $3.2B |
| Bausch Health Companies IncBHC | 51 | $3.2B |
| Dyne Therapeutics IncDYN | 52 | $3.1B |
Common questions
What sector and industry is Arcutis Biotherapeutics in?
Arcutis Biotherapeutics is in the Healthcare sector and the Drugs industry.
What is Arcutis Biotherapeutics' Tenet Score?
Arcutis Biotherapeutics' Tenet Score is 43 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




